The Russian government is considering providing support to the domestic pharmaceutical producers planning to export their drugs, according to recent statements by Russia’s Prime-Minister Dmitry Medvedev, reports The Pharma Letter’s local correspondent.
It is planned that the majority of subsidies will be provided for the conduct of clinical trials of their drugs abroad.
The Russian government hopes to begin the provision of subsidies no later than on September, 1 of the current year. There is a possibility that financial support should be also provided to global drugmakers operating plants in Russia.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze